M&G’s Catalyst invests $57mn in SkyCell

SkyCell transports more than $1.5 billion of pharma goods per month delivering hundreds of million doses of vaccines, cancer treatments, diabetes care and diagnostic solutions to patients around the world.

We are delighted to welcome M&G as a long-term partner as we continue our global expansion. SkyCell’s containers save up to 50% of CO2 emissions compared to traditional cold chain containers & minimise landfill throwaway packaging. With this new investment, we can accelerate our growth path and strengthen our global footprint: Richard Ettl, SkyCell

We are delighted to join SkyCell on its mission to deliver life-saving drugs globally in a safe and reliable manner. We believe the innovative design of the SkyCell solution will play a key role in decarbonising the pharmaceutical supply chain and ensure zero waste: Praveg Patil, M&G Catalyst

Click Here to Read More:

Click Here For More Stories